HLA-DRB1 molecule offers potential target for CAR therapy in relapsed acute myeloid leukemia post-transplantation
One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...
The Munich Eye1d
Targeting HLA-DRB1 Molecule: A New Frontier in CAR Therapy for Relapsed Acute Myeloid Leukemia
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
EurekAlert!4d
Driving the CAR to fight acute myeloid leukemia
This finding indicates that HLA-DRB1 can be a potential target in treating certain patients with AML who have relapsed after allo-HCT. The team then engineered KG2032 CAR T cells without the ...